ClinicalTrials.gov
ClinicalTrials.gov Menu

Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02304562
Recruitment Status : Unknown
Verified November 2014 by Xiaobing Fu, Chinese PLA General Hospital.
Recruitment status was:  Recruiting
First Posted : December 2, 2014
Last Update Posted : December 2, 2014
Sponsor:
Information provided by (Responsible Party):
Xiaobing Fu, Chinese PLA General Hospital

Brief Summary:
Patients with skin injury treated with Umbilical Cord Blood-derived Mesenchymal Stem Cells,such as deep burn damaged sweat glands,Effectiveness of Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair is determined.

Condition or disease Intervention/treatment Phase
Sweat Gland Diseases Biological: UCB Mesenchymal Stem Cells treatment Phase 1

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 50 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Umbilical Cord Blood-derived Mesenchymal Stem Cells in Regeneration of Sweat Glands and Body Repair
Study Start Date : January 2013
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2017

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sweat
U.S. FDA Resources

Arm Intervention/treatment
Experimental: UCB Mesenchymal Stem Cells
UCB Mesenchymal Stem Cells treatment of patients with skin injury
Biological: UCB Mesenchymal Stem Cells treatment
reduce skin injury



Primary Outcome Measures :
  1. Frequency of Adverse Events [ Time Frame: 6 months ]
    Frequency and severity of Adverse Events


Secondary Outcome Measures :
  1. Active and inactive lesion count [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Burn area:10-20%TBSA

Exclusion Criteria:

  • Have influence on the speed of wound healing of patients with chronic diseases

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02304562


Contacts
Contact: xiaobing FU +86(10)937516

Locations
China, Beijing
Chinese PLA General Hospital Recruiting
Beijing, Beijing, China, 100039
Contact: haojie Hao    +86(10)937516      
Contact: haojie Hao    +86(10)937516    haojieh@163.com   
Sponsors and Collaborators
Chinese PLA General Hospital
Investigators
Principal Investigator: xiaobing FU Chinese PLA General Hospital

Publications:
Responsible Party: Xiaobing Fu, Academician, Chinese PLA General Hospital
ClinicalTrials.gov Identifier: NCT02304562     History of Changes
Other Study ID Numbers: CHIN-PLAGH-ST-004
First Posted: December 2, 2014    Key Record Dates
Last Update Posted: December 2, 2014
Last Verified: November 2014

Additional relevant MeSH terms:
Sweat Gland Diseases
Skin Diseases